Skip to main content

Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels

Fluidigm has announced new line of high-parameter Maxpar mass cytometry panels for immuno-oncology. Designed for use with the firm's Helios and CyTOF systems, the panels enable researchers to profile T cell subpopulations across 34 markers to identify all major T cell subsets, measure checkpoint molecule expression, identify activation states, and determine homing status. Provided as a modular panel system, researchers can combine the panels for complete coverage and customize individual panel sets with additional markers.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.